Skip to main content
Premium Trial:

Request an Annual Quote

Talis Biomedical: Rebecca Markovich

Talis Biomedical said in a document filed with the US Securities and Exchange Commission that it has appointed Rebecca Markovich interim CFO, effective April 21. She replaces Roger Moody who will become CEO of Biocartis, effective April 24. Markovich has served as Talis' VP, controller since May 2022. Before that she was VP, accounting. Before joining Talis, Markovich was VP global controller at respiratory company Vyaire.